Shadow AI in Biotech: Risks of Unsanctioned Usage
Explore shadow AI in biotech and life sciences. This report details unsanctioned generative AI usage, data privacy risks, and enterprise governance strategies.
Back to Articles
Articles tagged with “biotech-ai”
Measuring AI ROI in Drug Discovery: Key Metrics & Outcomes
Learn how to measure AI ROI in drug discovery beyond cost and time savings. Updated for 2026 with 173+ AI clinical programs, Insilico's Phase IIa results, Recursion-Exscientia merger, and new FDA guidance. Key metrics for scientific outcomes, pipeline productivity, and commercial value.
AI Patents in Pharma: Ranking the Top 25 Companies (2025)
Explore our 2025 analysis of the top 25 pharmaceutical companies by AI patent filings. Learn who leads in AI R&D, key technology areas, and strategic trends.
RLHF Platforms in Biotech: Scale vs. Labelbox vs. In-House
An in-depth analysis of RLHF platforms for biotech (updated Feb 2026). Compare Scale AI (post-Meta deal), Labelbox, Appen, Surge AI, and in-house solutions on capabilities, cost, and HIPAA compliance.